Clinical infections and multiple sclerosis: Contribution from analytical epidemiology

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Casetta, Ilaria ^a   Granieri, Enrico ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Epidemiology; Infectious diseases; Multiple sclerosis

Indexed keywords

BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MULTIPLE SCLEROSIS; MUMPS; NORMAL HUMAN; PRIORITY JOURNAL; RUBELLA; VIRUS INFECTION;

HUMANS; MULTIPLE SCLEROSIS; VIRUS DISEASES;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 4; RUBELLA VIRUS;

EID: 0034077488     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Alter M, Cendrowski W (1976). Multiple sclerosis and childhood infections. Neurology 26: 201-204.
2. Alter M, Speer J (1968). Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 18: 109-116.
3. Alter M, Zhen-xin Z, Davanipour Z, Sobel E, Zibulewski J, Schwartz G, Friday G (1986). Multiple sclerosis and childhood infections. Neurology 36: 1386-1389.
4. Andersen E, Isager H, Hyllested K (1981). Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infections, tonsillectomy and appendectomy. Acta Neurol Scand 63: 131-135.
5. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A (1993). Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240: 417-422.
6. Bachmann S, Kesserling J (1998). Multiple sclerosis and infectious childhood diseases. Neuroepidemiology 17: 154-160.
7. Bansil S, Singhal BS, Ahuja GK, Riise T, Ladiwala U, Behari M, Cook SD (1996). Multiple sclerosis in India: a case-control study of environmental exposures. Acta Neurol Scand 95: 90-95.
8. Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Alperovith A (1989). Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand 80: 46-50.
9. Casetta I, Granieri E, Malagù S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E (1994). Environmental risk factors and multiple sclerosis: a community-based case-control study in the province of Ferrara, Italy. Neuroepidemiology 13: 120-127.
10. Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M (1969). Epidemiological study of multiple sclerosis in western Poland. Eur Neurol 2: 90-108.
11. Compston DAS, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Minis CA (1986). Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain 109: 325-344.
12. Currier RD, Martin EA, Woosley PC (1974). Prior events in multiple sclerosis. Neurology 24: 748-754.
13. Edwards S, Zvartau M, Clarks H, Irving W, Blumhardt LD (1998). Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64: 736-741.
14. Granieri E, Casetta I, Tola MR, Govoni V, Paolino E, Malagu S, Monetti VC, Carreras M (1993). Multiple sclerosis: does epidemiology contribute to providing etiological clues? J Neurol Sci 115 (Suppl): 16-23.
15. Granieri E, Casetta I (1997). Common childhood and adolescence infections and multiple sclerosis. Neurology 49 (Suppl. 2): S42-S54.
16. Gronning M, Riise T, Kvale G, Albrektsen G, Midgard R, Nyland H (1993). Infections in childhood and adolescence in multiple sclerosis. A case-control study. Neuroepidemiology 12: 61-69.
17. Gusev E, Boiko A, Lauer K, Riise Y, Deomina T (1996). Environmental risk factors in MS: a case-control study in Moskow. Acta Neurol Scand 94: 386-394.
18. Haahr S, Koch-Henriksen N, Moller-Larsen LS, Andersen HM (1995). Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler 1: 73-77.
19. Haahr S, Sommerlund M, Moller-Larsen A, Morgensen S, Andersen HMK (1992). Is multiple sclerosis caused by a dual infection with Retrovirus and Epstein-Barr Virus? Neuroepidemiology 11: 299-303.
20. Haile R, Smith P, Read D, Nassim D, Warlow C, Russel WC (1982). A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls. J Neurol Sci 56: 1-10.
21. Hays P (1992). Multiple sclerosis and delayed mumps. Acta Neurol Scand 85: 200-203.
22. Hopkins RS, Indian RW, Pinnow E, Conomy J (1991). Multiple sclerosis in galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 10: 192-199.
23. Italian Multiple Sclerosis Study Group (1989). Migration and infectious diseases in etiology of multiple sclerosis: a case-control study. In: Multiple sclerosis research. Battaglia MA, (ed). Elsevier Science publisher: Amsterdam, pp 147-156.
24. Koch-Henriksen N (1989). An epidemiological study of multiple sclerosis, familial aggregation, social determinants, and exogenic factors. Acta Neurol Scand 80 (Suppl. 124): 1-123.
25. Kurtzke JF (1993). Epidemiologic evidence of multiple sclerosis as an infection. Clin Microbiol Rev 6: 382-427.
26. Kurtzke JF, Hyllested K, Arbuckle JD, Bronnum-Hansen H, Wallin MT, Heltberg A, Jacobsen H, Olsen A, Eriksen LS (1997). Multiple sclerosis in the Faroe islands. 7. Results of a case-control questionnaire with multiple controls. Acta Neurol Scand 96: 149-157.
27. Lauer K, Firnhaber W (1994). Descriptive and analytical epidemiological data on multiple sclerosis from a long-term study in southern Hesse, Germany. In: Multiple sclerosis in Europe. An epidemiological update. Lauer K, Firnhaber W, (eds). Lechtturm-Verlag/LTV Press: Alsbach-Bergstrasse, pp 47-158.
28. Lindberg C, Andersen O, Vahlne A, Dalton M, Runmarker B (1991). Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991: 62-65.
29. Lowis GW (1990). The social epidemiology of multiple sclerosis. Sci Total Environ 90: 163-190.
30. Martyn CN, Cruddas M, Compston DAS (1993). Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 56: 167-168.
31. Materljan E (1994). Magnitude and distribution of multiple sclerosis in Gorski kotar, Croatia. Thesis.
32. Metz LM, McGuinness SD, Harris C (1998). Urinary tract infections may trigger relapse in multiple sclerosis. Axone 19: 67-70.
33. Milonas I. Epidemiological data of multiple sclerosis in northern Greece (1994). In: Multiple sclerosis in Europe. An epidemiological update. Lauer K, Firnhaber W, (eds), Lechtturm-Verlag/LTV Press: Alsbach-Bergstrasse, pp 332-333.
34. Morgensen S (1997). Proceedings of the 4th International Symposium on retrovirus in Multiple Sclerosis and relater disorders. Acta Neurol Scand 169 (Suppl.): 3-98.
35. Munch M, Hvas J, Christensen T, Moller-Larsen A, Haar S (1997). The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand (Suppl. 169): 59-64.
36. Munch M, Riisom K, Christensen T, Moller-Larsen A, Haahr S (1998). The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients. Acta Neurol Scand 97: 171-174.
37. Operskalski EA, Visscher BR, Malmgren RM, Detels R (1989). A case-control study of multiple sclerosis. Neurology 39: 825-829.
38. Panelius M, Salmi A, Halonen PE, Kivalo E, Rinne UK, Penttinen K (1973). Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls. A final report. Acta Neurol Scand 49: 85-107.
39. Poskanzer DC, Sheridan JE, Prenney EB, Walker AM (1980). Multiple sclerosis in the Orkney and Shetland islands. II. The search for an exogenous aetiology. J Epidemiol Comm Health 34: 240-252.
40. Rapp NS, Gilroy J, Lerner AM (1995). Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 74: 415-418.
41. Riise T, Gronning M, Klauber MR, Barrett-Connor E, Nyland H, Albrektsen G (1991). Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 133: 932-939.
42. Sibley WA, Bamford CR, Clark K (1985). Clinical viral infections and multiple sclerosis. Lancet i: 1313-1351.
43. Souberbielle BE, Martin-Mondiore C, O'Brien ME, Carydakis C, Cesaro P, Degos JD (1990). A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand 82: 303-310.
44. Sullivan CB, Visscher B, Detels R (1984). Multiple sclerosis and age at exposure to childhood diseases and animals: cases and their friends. Neurology 34: 1144-1148.
45. Wilhelm ES (1970). Beziehungenn zwischen Erkrankurgen in Kindersalter und Multiple Sklerose Erkrankrung. Schweiz Arch Neurol Psichiatry 106: 311-317.
46. Zilber N, Kahana E (1996). Risk factors for multiple sclerosis: a case-control study in Israel. Acta Neurol Scand 94: 395-403.